Cargando…

Interferon Treatment of Hepatitis C Reinfection after Liver Transplantation: A Meta-Analysis

Background. Graft reinfection with hepatitis C (HCV) after liver transplantation is a significant problem in transplant hepatology. This meta-analysis was performed to compare the effectiveness and risk of adverse events of interferon-based therapy with no treatment after liver transplantation. Meth...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Yaqin, Wu, Gang, Zhang, Hongmin, Xu, Hua, Li, Hong, Chen, Ling, Yang, Yixuan, Hu, Peng, Zhang, Dazhi, Ren, Hong, Hu, Huaidong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2015
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4488578/ https://www.ncbi.nlm.nih.gov/pubmed/26167174 http://dx.doi.org/10.1155/2015/206302

Ejemplares similares

Enhanced Functions of Peripheral γδ T Cells in Chronic Hepatitis B Infection during Interferon α Treatment In Vivo and In Vitro
por: Chen, Min, et al.
Publicado: (2015)

Interferon-Based Anti-Viral Therapy for Hepatitis C Virus Infection after Renal Transplantation: An Updated Meta-Analysis
por: Wei, Fang, et al.
Publicado: (2014)

Efficacy and Safety of Pegylated Interferon Plus Ribavirin Therapy for Chronic Hepatitis C Genotype 6: A Meta-Analysis
por: Wang, Xiwei, et al.
Publicado: (2014)

Efficacy and safety of oral branched-chain amino acid supplementation in patients undergoing interventions for hepatocellular carcinoma: a meta-analysis
por: Chen, Ling, et al.
Publicado: (2015)

Coffee Consumption Decreases Risks for Hepatic Fibrosis and Cirrhosis: A Meta-Analysis
por: Liu, Fen, et al.
Publicado: (2015)

Efficacy and resistance in de novo combination lamivudine and adefovir dipivoxil therapy versus entecavir monotherapy for the treatment-naive patients with chronic hepatitis B: a meta-analysis
por: Liu, Fen, et al.
Publicado: (2014)

Consensus on Pegylated Interferon Alpha in Treatment of Chronic Hepatitis B
por: Zhang, Wenhong, et al.
Publicado: (2018)

Efficacy of PEGylated Interferon in Treatment-Experienced Chinese Patients With HBeAg Positive Chronic Hepatitis B
por: Xiong, Yue-Li, et al.
Publicado: (2016)

Production of Autoantibodies in Chronic Hepatitis B Virus Infection Is Associated with the Augmented Function of Blood CXCR5(+)CD4(+) T Cells
por: Lei, Yu, et al.
Publicado: (2016)

Modulation of HCV reinfection after orthotopic liver transplantation by fibroblast growth factor-2 and other non-interferon mediators
por: Van, Nguyen Dinh, et al.
Publicado: (2016)

Combination therapy with silibinin, pegylated interferon and ribavirin in a patient with hepatitis C virus genotype 3 reinfection after liver transplantation: a case report
por: Knapstein, Johanna, et al.
Publicado: (2014)

Functional dichotomy of Vδ2 γδ T cells in chronic hepatitis C virus infections: role in cytotoxicity but not for IFN-γ production
por: Yin, Wenwei, et al.
Publicado: (2016)

Viral entry and escape from antibody-mediated neutralization influence hepatitis C virus reinfection in liver transplantation
por: Fafi-Kremer, Samira, et al.
Publicado: (2010)

A Comprehensive Hepatitis B Surface Antigen-Positive Patient-Centered Screening and Linkage to Care Strategies Targeting Microelimination of Hepatitis C Virus Infection in Chongqing, China
por: Cai, Dachuan, et al.
Publicado: (2022)

LHBs can elevate the expression of MDR1 through HIF-1α in patients with CHB infection: a comparative proteomic study
por: Li, Shiying, et al.
Publicado: (2016)

Identification of the fatty acid synthase interaction network via iTRAQ-based proteomics indicates the potential molecular mechanisms of liver cancer metastasis
por: Huang, Juan, et al.
Publicado: (2020)

The influence of hepatitis B virus on antiviral treatment with interferon and ribavirin in Asian patients with hepatitis C virus/hepatitis B virus coinfection: a meta-analysis
por: Liu, Jun-Ying, et al.
Publicado: (2012)

Effects of probiotics on nonalcoholic fatty liver disease: a systematic review and meta-analysis
por: Tang, Yao, et al.
Publicado: (2019)

Single nucleotide polymorphisms of the IL28B and sustained virologic response of patients with chronic hepatitis C to PEG-interferon/ribavirin therapy: A meta-analysis: Meta-analysis of IL28B
por: Li, Shiying, et al.
Publicado: (2011)

COVID-19 diverse outcomes: Aggravated reinfection, type I interferons and antibodies
por: Costa Silva, Rafael Cardoso Maciel, et al.
Publicado: (2022)

Efficacy of Tenofovir-Based Combination Therapy versus Tenofovir Monotherapy in Chronic Hepatitis B Patients Presenting with Suboptimal Responses to Pretreatment: A Meta-Analysis
por: Chen, Ling, et al.
Publicado: (2016)

A panel of urine-derived biomarkers to identify sepsis and distinguish it from systemic inflammatory response syndrome
por: Tang, Yao, et al.
Publicado: (2021)

Helicobacter pylori reinfection and its risk factors after initial eradication: A protocol for systematic review and meta-analysis
por: Li, Renliang, et al.
Publicado: (2021)

Pegylated Interferon Treatment for the Effective Clearance of Hepatitis B Surface Antigen in Inactive HBsAg Carriers: A Meta-Analysis
por: Song, Aixin, et al.
Publicado: (2021)

Serum hepatitis B virus DNA before liver transplantation correlates with HBV reinfection rate even under successful low-dose hepatitis B immunoglobulin prophylaxis
por: Yasunaka, Tetsuya, et al.
Publicado: (2011)

Reestablishment of Active Immunity against HBV Graft Reinfection after Liver Transplantation for HBV-Related End Stage Liver Disease
por: Lu, Shi-Chun, et al.
Publicado: (2014)

COVID-19 reinfection in a kidney transplant recipient
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2023)

COVID-19 reinfection in a kidney transplant recipient
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2023)

Chronic hepatitis E after kidney transplantation with an antibody response suggestive of reinfection: a case report
por: Panning, Marcus, et al.
Publicado: (2019)

Salivary orosomucoid 1 as a biomarker of hepatitis B associated hepatocellular carcinoma
por: He, Jiaoxia, et al.
Publicado: (2022)

Association between immunosuppressants and poor antibody responses to SARS-CoV-2 vaccines in patients with autoimmune liver diseases
por: Li, Hu, et al.
Publicado: (2022)

Tolerability and efficacy of pegylated consensus interferon-α in the treatment of chronic hepatitis C
por: Ding, Yan-Hua, et al.
Publicado: (2017)

COVID-19 reinfection in the presence of neutralizing antibodies
por: Zhang, Ju, et al.
Publicado: (2021)

Decreased antibody response to influenza vaccine with an enhanced antibody response to subsequent SARS‐CoV‐2 vaccination in patients with chronic hepatitis B virus infection
por: He, Taiyu, et al.
Publicado: (2022)

The Survival Benefit of Liver Transplantation for Hepatocellular Carcinoma Patients with Hepatitis B Virus Infection and Cirrhosis
por: Zhang, Qing, et al.
Publicado: (2012)

Failure of Intravenous Silibinin Monotherapy to Prevent Hepatitis C Genotype 2A Liver Graft Reinfection
por: Aghemo, Alessio, et al.
Publicado: (2012)

Higher baseline viral diversity correlates with lower HBsAg decline following PEGylated interferon-alpha therapy in patients with HBeAg-positive chronic hepatitis B
por: Li, Hu, et al.
Publicado: (2018)

Association between immunosuppressants and poor antibody responses to inactivated SARS-CoV-2 vaccines in patients with autoimmune liver diseases
por: Li, Hu, et al.
Publicado: (2022)

COVID-19 reinfection: prolonged shedding or true reinfection?
por: Falahi, S., et al.
Publicado: (2020)

COVID‐19 reinfection or reactivation in a renal transplant patient
por: Abolghasemi, Sara, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8nqiehttg8mm0qm7cu0irtq5mb